Table 1.
Demographics and laboratory investigations for patients prior to and following ASP implementation
| Patients’ characteristics | Prior to ASP n = 109 (64.9%) | Following ASP n = 59 (35.1%) | Total N = 168 (100%) | P value | |
|---|---|---|---|---|---|
| Age in years | Mean (SD) | 60.0 (17.0) | 55.3 (16.4) | 58.4 (16.9) | 0.084 |
| Min – Max | 27.0–94.0 | 18.0–84.0 | 18.0–94.0 | ||
| Gender | Female | 58 (53.2) | 27 (45.8) | 85 (50.6) | 0.447 |
| Male | 51 (46.8) | 32 (54.2) | 83 (49.4) | ||
| BMI | Mean (SD) | 27.5 (3.1) | 30.5 (6.6) | 28.6 (4.8) | 0.001** |
| Min – Max | 15.6–36.7 | 18.7–58.5 | 15.6–58.5 | ||
| Highest creatinine level (mg/dl) | Mean (SD) | 2.7 (2.5) | 2.5 (2.0) | 2.6 (2.3) | 0.464 |
| Min – Max | 0.8–9.2 | 0.7–8.2 | 0.7–9.2 | ||
| Lowest creatinine level (mg/dl) | Mean (SD) | 1.8 (1.5) | 1.6 (1.5) | 1.7 (1.5) | 0.482 |
| Min – Max | 0.7–5.8 | 0.4–6.4 | 0.4–6.4 | ||
| Highest platelets level (× 1000/mcL) | Mean (SD) | 253.9 (89.2) | 277.5 (169.6) | 262.1 (123.5) | 0.332 |
| Min – Max | 95.0–450.0 | 50.0–999.0 | 50.0–999.0 | ||
| Lowest platelets level (× 1000/mcL) | Mean (SD) | 189.9 (67.9) | 198.8 (125.8) | 193.0 (92.2) | 0.607 |
| Min – Max | 75.0–400.0 | 21.0–589.0 | 21.0–589.0 | ||
**0.01 >p value ≥ 0.001